Selected research
Industry Research
Omics Data Analysis Service Industry Research Report 2026
Market perspective
The global Omics Data Analysis Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Omics Data Analysis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Omics Data Analysis Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Omics Data Analysis Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Omics Data Analysis Service include Acobiom, AltraBio, BGI Genomics, Biogenity, Tempus, Cmbio, Creative Proteomics, Firalis Molecular Precision and Metware Biotechnology, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Omics Data Analysis Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Omics Data Analysis Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Omics Data Analysis Service Market by Company
Acobiom
AltraBio
BGI Genomics
Biogenity
Tempus
Cmbio
Creative Proteomics
Firalis Molecular Precision
Metware Biotechnology
Nuvisan
Omics Data Solutions
PharmaLex
Standard BioTools
PIPA AI
Seven Bridges
Omics Data Analysis Service Segment by Type
Genomic Analysis
Transcriptomic Analysis
Proteomic Analysis
Metabolomic Analysis
Epigenomic Analysis
Microbiome Analysis
Others
Omics Data Analysis Service Segment by Application
Developmental Biology
Clinical Medicine
Precision Diagnosis
Drug Development
Others
Omics Data Analysis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omics Data Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omics Data Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omics Data Analysis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Omics Data Analysis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Genomic Analysis
- Transcriptomic Analysis
- Proteomic Analysis
- Metabolomic Analysis
- Epigenomic Analysis
- Microbiome Analysis
- Others
Applications
- Developmental Biology
- Clinical Medicine
- Precision Diagnosis
- Drug Development
- Others
Companies covered
- Acobiom
- AltraBio
- BGI Genomics
- Biogenity
- Tempus
- Cmbio
- Creative Proteomics
- Firalis Molecular Precision
- Metware Biotechnology
- Nuvisan
- Omics Data Solutions
- PharmaLex
- Standard BioTools
- PIPA AI
- Seven Bridges
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Omics Data Analysis Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Genomic Analysis
- 2.2.3 Transcriptomic Analysis
- 2.2.4 Proteomic Analysis
- 2.2.5 Metabolomic Analysis
- 2.2.6 Epigenomic Analysis
- 2.2.7 Microbiome Analysis
- 2.2.8 Others
- 2.3 Omics Data Analysis Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Developmental Biology
- 2.3.3 Clinical Medicine
- 2.3.4 Precision Diagnosis
- 2.3.5 Drug Development
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Omics Data Analysis Service Breakdown Data by Type
- 3.1 Global Omics Data Analysis Service Historic Market Size by Type (2021-2026)
- 3.2 Global Omics Data Analysis Service Forecasted Market Size by Type (2027-2032)
4 Omics Data Analysis Service Breakdown Data by Application
- 4.1 Global Omics Data Analysis Service Historic Market Size by Application (2021-2026)
- 4.2 Global Omics Data Analysis Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Omics Data Analysis Service Market Perspective (2021-2032)
- 5.2 Global Omics Data Analysis Service Growth Trends by Region
- 5.2.1 Global Omics Data Analysis Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Omics Data Analysis Service Historic Market Size by Region (2021-2026)
- 5.2.3 Omics Data Analysis Service Forecasted Market Size by Region (2027-2032)
- 5.3 Omics Data Analysis Service Market Dynamics
- 5.3.1 Omics Data Analysis Service Industry Trends
- 5.3.2 Omics Data Analysis Service Market Drivers
- 5.3.3 Omics Data Analysis Service Market Challenges
- 5.3.4 Omics Data Analysis Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Omics Data Analysis Service Players by Revenue
- 6.1.1 Global Top Omics Data Analysis Service Players by Revenue (2021-2026)
- 6.1.2 Global Omics Data Analysis Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Omics Data Analysis Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Omics Data Analysis Service Head Office and Area Served
- 6.4 Global Omics Data Analysis Service Players, Product Type & Application
- 6.5 Global Omics Data Analysis Service Manufacturers Established Date
- 6.6 Global Omics Data Analysis Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Omics Data Analysis Service Market Size (2021-2032)
- 7.2 North America Omics Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Omics Data Analysis Service Market Size by Country (2021-2026)
- 7.4 North America Omics Data Analysis Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Omics Data Analysis Service Market Size (2021-2032)
- 8.2 Europe Omics Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Omics Data Analysis Service Market Size by Country (2021-2026)
- 8.4 Europe Omics Data Analysis Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Omics Data Analysis Service Market Size (2021-2032)
- 9.2 Asia-Pacific Omics Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Omics Data Analysis Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Omics Data Analysis Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Omics Data Analysis Service Market Size (2021-2032)
- 10.2 South America Omics Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Omics Data Analysis Service Market Size by Country (2021-2026)
- 10.4 South America Omics Data Analysis Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Omics Data Analysis Service Market Size (2021-2032)
- 11.2 Middle East & Africa Omics Data Analysis Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Omics Data Analysis Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Omics Data Analysis Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Acobiom
- 12.1.1 Acobiom Company Information
- 12.1.2 Acobiom Business Overview
- 12.1.3 Acobiom Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.1.4 Acobiom Omics Data Analysis Service Product Portfolio
- 12.1.5 Acobiom Recent Developments
- 12.2 AltraBio
- 12.2.1 AltraBio Company Information
- 12.2.2 AltraBio Business Overview
- 12.2.3 AltraBio Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.2.4 AltraBio Omics Data Analysis Service Product Portfolio
- 12.2.5 AltraBio Recent Developments
- 12.3 BGI Genomics
- 12.3.1 BGI Genomics Company Information
- 12.3.2 BGI Genomics Business Overview
- 12.3.3 BGI Genomics Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.3.4 BGI Genomics Omics Data Analysis Service Product Portfolio
- 12.3.5 BGI Genomics Recent Developments
- 12.4 Biogenity
- 12.4.1 Biogenity Company Information
- 12.4.2 Biogenity Business Overview
- 12.4.3 Biogenity Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.4.4 Biogenity Omics Data Analysis Service Product Portfolio
- 12.4.5 Biogenity Recent Developments
- 12.5 Tempus
- 12.5.1 Tempus Company Information
- 12.5.2 Tempus Business Overview
- 12.5.3 Tempus Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.5.4 Tempus Omics Data Analysis Service Product Portfolio
- 12.5.5 Tempus Recent Developments
- 12.6 Cmbio
- 12.6.1 Cmbio Company Information
- 12.6.2 Cmbio Business Overview
- 12.6.3 Cmbio Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.6.4 Cmbio Omics Data Analysis Service Product Portfolio
- 12.6.5 Cmbio Recent Developments
- 12.7 Creative Proteomics
- 12.7.1 Creative Proteomics Company Information
- 12.7.2 Creative Proteomics Business Overview
- 12.7.3 Creative Proteomics Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.7.4 Creative Proteomics Omics Data Analysis Service Product Portfolio
- 12.7.5 Creative Proteomics Recent Developments
- 12.8 Firalis Molecular Precision
- 12.8.1 Firalis Molecular Precision Company Information
- 12.8.2 Firalis Molecular Precision Business Overview
- 12.8.3 Firalis Molecular Precision Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.8.4 Firalis Molecular Precision Omics Data Analysis Service Product Portfolio
- 12.8.5 Firalis Molecular Precision Recent Developments
- 12.9 Metware Biotechnology
- 12.9.1 Metware Biotechnology Company Information
- 12.9.2 Metware Biotechnology Business Overview
- 12.9.3 Metware Biotechnology Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.9.4 Metware Biotechnology Omics Data Analysis Service Product Portfolio
- 12.9.5 Metware Biotechnology Recent Developments
- 12.10 Nuvisan
- 12.10.1 Nuvisan Company Information
- 12.10.2 Nuvisan Business Overview
- 12.10.3 Nuvisan Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.10.4 Nuvisan Omics Data Analysis Service Product Portfolio
- 12.10.5 Nuvisan Recent Developments
- 12.11 Omics Data Solutions
- 12.11.1 Omics Data Solutions Company Information
- 12.11.2 Omics Data Solutions Business Overview
- 12.11.3 Omics Data Solutions Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.11.4 Omics Data Solutions Omics Data Analysis Service Product Portfolio
- 12.11.5 Omics Data Solutions Recent Developments
- 12.12 PharmaLex
- 12.12.1 PharmaLex Company Information
- 12.12.2 PharmaLex Business Overview
- 12.12.3 PharmaLex Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.12.4 PharmaLex Omics Data Analysis Service Product Portfolio
- 12.12.5 PharmaLex Recent Developments
- 12.13 Standard BioTools
- 12.13.1 Standard BioTools Company Information
- 12.13.2 Standard BioTools Business Overview
- 12.13.3 Standard BioTools Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.13.4 Standard BioTools Omics Data Analysis Service Product Portfolio
- 12.13.5 Standard BioTools Recent Developments
- 12.14 PIPA AI
- 12.14.1 PIPA AI Company Information
- 12.14.2 PIPA AI Business Overview
- 12.14.3 PIPA AI Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.14.4 PIPA AI Omics Data Analysis Service Product Portfolio
- 12.14.5 PIPA AI Recent Developments
- 12.15 Seven Bridges
- 12.15.1 Seven Bridges Company Information
- 12.15.2 Seven Bridges Business Overview
- 12.15.3 Seven Bridges Revenue in Omics Data Analysis Service Business (2021-2026)
- 12.15.4 Seven Bridges Omics Data Analysis Service Product Portfolio
- 12.15.5 Seven Bridges Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst